Bristol Myers Squibb (BMY)

EBITDA Margin

34.19%

TTM · Period ending:

BMY logo

BMY EBITDA Margin

Latest reported34.19%
BMY TTM EBITDA Margin (19.41% → 34.19%)
High-resolution chart · PNG

BMY ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Bristol Myers Squibb EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
34.1879%
30.9346%
31.6008%
31.0239%
31.5906%
34.0163%
6.559%
10.6904%
11.0731%
11.6836%
43.0298%
43.5874%
43.8843%
43.8645%
41.6409%
41.309%
41.1993%
40.8092%
43.3718%
17.4892%
18.02%
18.5587%
11.5927%
34.8293%
29.2353%
24.892%
28.2157%
31.9199%
35.0547%
30.1185%
30.0873%
27.2678%
23.3889%
27.999%
29.4378%
31.2008%
33.1307%
34.5304%
33.2733%
26.6634%
24.702%
16.5405%
15.9239%
18.2929%
18.684%
21.5904%
19.2141%
25.2646%
24.2626%
25.0046%
23.5154%
21.7725%
9.1927%
11.9252%
18.1772%
22.6806%
35.4023%
37.3999%
36.7869%
36.4815%
36.7938%
36.9565%
35.7216%
36.6696%
35.1145%
33.5538%
31.8109%
33.9484%
32.4371%
31.4994%
31.8093%
25.7598%
24.5081%
22.7098%
20.798%
19.2961%
18.0012%
19.2277%
19.8057%
22.2917%
24.2177%
24.6447%
25.4074%
28.7792%
28.906%
28.0978%
27.6419%
25.3023%
26.2165%
27.0455%
27.4576%
27.1338%
26.579%
25.8193%
28.7988%
31.6197%
33.3866%
35.523%
35.0821%
36.4122%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.